Követés
Katarzyna Kla¶
Katarzyna Kla¶
PhD Candidate, Jagiellonian University Medical College
E-mail megerősítve itt: doctoral.uj.edu.pl
Cím
Hivatkozott rá
Hivatkozott rá
Év
Saponins as chemosensitizing substances that improve effectiveness and selectivity of anticancer drug—Minireview of in vitro studies
P Koczurkiewicz, K Kla¶, K Grabowska, K Piska, K Rogowska, ...
Phytotherapy Research 33 (9), 2141-2151, 2019
242019
Cinnamic acid derivatives as cardioprotective agents against oxidative and structural damage induced by doxorubicin
P Koczurkiewicz-Adamczyk, K Kla¶, A Gunia-Krzyżak, K Piska, ...
International journal of molecular sciences 22 (12), 6217, 2021
122021
How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials. gov
N Hutchinson, K Klas, BG Carlisle, J Kimmelman, M Waligora
Plos one 17 (1), e0262114, 2022
82022
Bioethics of somatic gene therapy: what do we know so far?
P Buedo, A Bianchini, K Klas, M Waligora
Current Medical Research and Opinion 39 (10), 1355-1365, 2023
12023
Competition for recruitment in SARS-CoV-2 Trials in the United States: a longitudinal cohort analysis
N Hutchinson, K Klas, BG Carlisle, M Polak, J Kimmelman, M Waligora
BMC Research Notes 15 (1), 368, 2022
12022
Masking
M Waligora, K Klas
The SAGE Encyclopedia of Research Design 1, 860-861, 2022
12022
Synthesis, in Silico and in Vitro Study on Phase I Metabolism of the Potent 5-Ht7/5-Ht1a/D2 Receptor Ligand: 4-Fluoro n-(1-{2-[2-(Methylsulfanyl)-Phenoxy] Ethyl} Pyrrolidin-3 …
P Kubowicz-Kwa¶ny, K Piska, K Kla¶, P Żmudzki, V Canale, P Zajdel, ...
Pharmaceutical Chemistry Journal 53 (8), 713-719, 2019
12019
Similar Safety Profile of the Enantiomeric N-Aminoalkyl Derivatives of Trans-2-Aminocyclohexan-1-ol Demonstrating Anticonvulsant Activity
K Słoczyńska, P Koczurkiewicz, K Piska, B PowroĽnik, K Wójcik-Pszczoła, ...
Molecules 24 (13), 2505, 2019
12019
The informativeness of trials in COVID-19: Lessons learned from the Coronavirus pandemic
N Hutchinson, B Carlisle, K Klas, M Polak, J Kimmelman, M Waligora
1
Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed
G Nilsonne, S Wieschowski, NJ DeVito, M Salholz-Hillel, T Bruckner, ...
medRxiv, 2024.02. 04.24301363, 2024
2024
Ethical challenges of clinical trials with a repurposed drug in outbreaks
K Klas, K Strzebonska, M Waligora
Medicine, Health Care and Philosophy 26 (2), 233-241, 2023
2023
Saponin Fraction CIL1 from Lysimachia ciliata L. Enhances the Effect of a Targeted Toxin on Cancer Cells
P Koczurkiewicz-Adamczyk, K Grabowska, E Karnas, K Piska, D Wnuk, ...
Pharmaceutics 15 (5), 1350, 2023
2023
REMEDY. Research Ethics in Medicine Study Group
M Waligora, M Polak, P Buedo, M Wasylewski, K Strzebonska, K Kla¶, ...
SAGE, 2022
2022
Badanie wła¶ciwo¶ci kardioprotekcyjnych pochodnych kwasu cynamonowego w modelu kardiomiocytów różnicowanych z ludzkich indukowanych pluripotencjalnych komórek macierzystych
K Kla¶
2019
Zastosowanie modeli in vitro w przedklinicznych badaniach bezpieczeństwa nowych kandydatów na leki
K Kla¶, P Guzy, K Piska, K Wójcik-Pszczoła, P Koczurkiewicz-Adamczyk, ...
Farmacja Polska 74 (1), 2018
2018
Saponin Fraction CIL1 from Lysimachia ciliata L
P Koczurkiewicz-Adamczyk, K Grabowska, E Karnas, K Piska, D Wnuk, ...
Enhances the Effect of a Targeted Toxin on Cancer Cells. Pharmaceutics, 0
Clinical trials in Poland: Reporting results on the European Union Clinical Trials Register
K Strzebonska, K Klas, L Bandura-Morgan, NJ DeVito, M Polak
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–17